Health care stocks fell Tuesday afternoon with the NYSE Health Care Index shedding 0.5% and the Health Care Select Sector SPDR Fund (XLV) down 0.4%.
The iShares Biotechnology ETF (IBB) was little changed, erasing earlier gains.
In corporate news, Surgery Partners (SGRY) shares jumped 18%. Bain Capital Partners delivered a non-binding proposal late Monday to Surgery Partners' board proposing to buy the remaining shares for $25.75 apiece in cash.
Silexion Therapeutics (SLXN) shares surged 79% after the company reported "promising" preclinical data from its tumor drug candidate, SIL-204, in mice.
Trinity Biotech (TRIB) shares jumped 53% after the company said the latest pre-pivotal trial for its continuous glucose monitoring technology yielded "breakthrough" results.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.